416 related articles for article (PubMed ID: 27015564)
21. Management of regional lymph nodes in the elderly melanoma patient: patient selection, accuracy and prognostic implications.
Grotz TE; Puig CA; Perkins S; Ballman K; Hieken TJ
Eur J Surg Oncol; 2015 Jan; 41(1):157-64. PubMed ID: 25468751
[TBL] [Abstract][Full Text] [Related]
22. Complete lymph node dissection for regional nodal metastasis.
Dzwierzynski WW
Clin Plast Surg; 2010 Jan; 37(1):113-25. PubMed ID: 19914463
[TBL] [Abstract][Full Text] [Related]
23. Principles of sentinel lymph node identification: background and clinical implications.
Cochran AJ; Essner R; Rose DM; Glass EC
Langenbecks Arch Surg; 2000 Jul; 385(4):252-60. PubMed ID: 10958508
[TBL] [Abstract][Full Text] [Related]
24. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P
Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients.
Howman-Giles R; Shaw HM; Scolyer RA; Murali R; Wilmott J; McCarthy SW; Uren RF; Thompson JF
Ann Surg Oncol; 2010 Jan; 17(1):138-43. PubMed ID: 19672660
[TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
28. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline.
Wright FC; Souter LH; Kellett S; Easson A; Murray C; Toye J; McCready D; Nessim C; Ghazarian D; Hong NJL; Johnson S; Goldstein DP; Petrella T;
Curr Oncol; 2019 Aug; 26(4):e541-e550. PubMed ID: 31548823
[TBL] [Abstract][Full Text] [Related]
29. Sentinel Lymph Node Dissection in Head and Neck Melanoma has Prognostic Impact on Disease-Free and Overall Survival.
Leiter U; Eigentler TK; Häfner HM; Krimmel M; Uslu U; Keim U; Weide B; Breuninger H; Martus P; Garbe C
Ann Surg Oncol; 2015 Nov; 22(12):4073-80. PubMed ID: 25712801
[TBL] [Abstract][Full Text] [Related]
30. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
31. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
32. Prognostic heterogeneity after the excision of lymph node metastases in patients with cutaneous melanoma.
Pilko G; Besic N; Zgajnar J; Hocevar M
Surg Oncol; 2011 Mar; 20(1):26-34. PubMed ID: 19900803
[TBL] [Abstract][Full Text] [Related]
33. Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis.
Nagaraja V; Eslick GD
Eur J Surg Oncol; 2013 Jul; 39(7):669-80. PubMed ID: 23571104
[TBL] [Abstract][Full Text] [Related]
34. Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.
Broer PN; Walker ME; Goldberg C; Buonocore S; Braddock DT; Lazova R; Narayan D; Ariyan S
Eur J Surg Oncol; 2013 Jul; 39(7):681-5. PubMed ID: 23522951
[TBL] [Abstract][Full Text] [Related]
35. Role of elective lymph node dissection in stage I malignant melanoma: evaluation by matched pair analysis.
Rompel R; Garbe C; Büttner P; Teichelmann K; Petres J
Recent Results Cancer Res; 1995; 139():323-36. PubMed ID: 7597301
[TBL] [Abstract][Full Text] [Related]
36. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
37. A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma.
van Poll D; Thompson JF; Colman MH; McKinnon JG; Saw RP; Stretch JR; Scolyer RA; Uren RF
Ann Surg Oncol; 2005 Aug; 12(8):597-608. PubMed ID: 16021534
[TBL] [Abstract][Full Text] [Related]
38. Is sentinel lymph node biopsy of therapeutic relevance for melanoma?
Möhrle M; Schippert W; Rassner G; Garbe C; Breuninger H
Dermatology; 2004; 209(1):5-13. PubMed ID: 15237261
[TBL] [Abstract][Full Text] [Related]
39. Does the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study.
Richtig G; Richtig E; Neiss AN; Quehenberger F; Gmainer DG; Kamolz LP; Lumenta DB
Int J Surg; 2020 Mar; 75():160-164. PubMed ID: 32036082
[TBL] [Abstract][Full Text] [Related]
40. Is therapeutic lymph node dissection of value for lymph node recurrence in melanoma?
Wilson AK; Lourdault K; Ostad T; Stern S; Essner R
Am J Surg; 2024 Feb; 228():258-263. PubMed ID: 37923660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
